Abstract
Reserpine in single doses of 0.03 mgm. and above, when given to the isolated dog heart-lung preparation, causes a heart-rate increasing effect. The effect has the appearance of a continuous infusion of epinephrine or norepinephrine and in the dosage range of 1 to 5 mgm. is similar to the effect of approximately 3 microgm./min. of either of the two catechol amines given over a period of about 50 minutes. Long lasting release of epinephrine and/or norepinephrine best explains the phenomenon. Reserpine, in doses of 5 mgm. or larger, given to the heart under the chronotropic influence of sympathomimetic amines, has a rate-decreasing action which resembles the antiaccelerator action of veratramine in that it is atropine-resistant and antagonizes the positive chronotropic effects of extraneously supplied sympathomimetic amines. Such doses also antagonize the rate-increasing effect of initial doses of reserpine. Measured against ephedrine, the antiaccelerator potency of reserpine in the dog heart-lung preparation is about [unknown] that of veratramine (on a molar basis). Doses of 20 mgm. of reserpine and above have a negative inotropic effect upon the isolated dog heart in the heart-lung preparation.
Footnotes
- Received February 13, 1958.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|